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Christopher Weinert, Damien Morger, Aleksandra Djekic, Markus G. Grütter & 
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Many tripartite motif-containing (TRIM) proteins, comprising RING-finger, B-Box, and coiled-coil 
domains, carry additional B30.2 domains on the C-terminus of the TRIM motif and are considered 
to be pattern recognition receptors involved in the detection of higher order oligomers (e.g. viral 
capsid proteins). To investigate the spatial architecture of domains in TRIM proteins we determined 
the crystal structure of the TRIM20Δ 413 fragment at 2.4 Å resolution. This structure comprises the 
central helical scaffold (CHS) and C-terminal B30.2 domains and reveals an anti-parallel arrangement 
of CHS domains placing the B-box domains 170 Å apart from each other. Small-angle X-ray scattering 
confirmed that the linker between CHS and B30.2 domains is flexible in solution. The crystal structure 
suggests an interaction between the B30.2 domain and an extended stretch in the CHS domain, 
which involves residues that are mutated in the inherited disease Familial Mediterranean Fever. 
Dimerization of B30.2 domains by means of the CHS domain is crucial for TRIM20 to bind pro-IL-1β in 
vitro. To exemplify how TRIM proteins could be involved in binding higher order oligomers we discuss 
three possible models for the TRIM5α /HIV-1 capsid interaction assuming different conformations of 
B30.2 domains.
Tripartite motif-containing proteins represent a large family of proteins sharing a conserved domain 
architecture. The tripartite motif (TRIM) consists of an N-terminal RING domain, one or two B-box 
domains and a C-terminal coiled-coil domain. The TRIM segment is considered to serve as a scaffold 
domain that is extended on either side by additional protein-protein interaction modules. The RING- 
and B-box domains contain zinc finger motifs that confer E3 ubiquitin ligase and self-association activ-
ities, respectively. TRIM proteins are involved in diverse cellular functions including regulation of the 
innate immune system, retroviral restriction, cell proliferation, and differentiation1,2.
TRIM20 (Uniprot ID: O15553), which is also named pyrin or marenostrin, is special among other 
TRIM proteins, because it lacks the RING domain that confers ubiquitin ligase activity. In TRIM20 the 
RING domain is replaced by a PYD domain, which belongs to the death domain superfamily and is 
frequently involved in homotypic protein-protein interactions (reviewed in ref 3.). Depending on the 
splice variant of TRIM20 the PYD domain is connected to the B-box domain by either a 60 or a 280 
amino acid long linker. Almost 50% of all TRIM proteins - including TRIM20 - carry a B30.2 domain 
immediately after the coiled-coil domain of the central TRIM motif (Fig. 1A). The B30.2 domain, which 
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was initially called PrySpry domain, because it consists of an N-terminal Pry- and a C-terminal Spry 
segment, is involved in heterotypic protein-protein interactions4. Although TRIM proteins can be recog-
nized by their characteristic signature sequence, their biological functions are often incompletely under-
stood. Many TRIM proteins act as cytoplasmic pattern recognition receptors that sense higher order 
oligomers, e.g. a lattice of viral capsid (CA) proteins (reviewed in ref 5.).
TRIM20 is associated with the auto-inflammatory disease Familial Mediterranean Fever (FMF) and 
it is involved in the modulation of the pro-inflammatory cytokine pro-interleukin-1β (pro-IL-1β )6,7. The 
pro-IL-1β /TRIM20 interaction is ambiguous. TRIM20 is considered to inhibit the inflammasome medi-
ated maturation of pro-IL-1β 8, but it can also potently induce the maturation of this cytokine9–12. The 
exact mechanism of regulation between these two contrary functions is currently unknown. TRIM5α 
and TRIM21 are two well-studied examples of TRIM proteins involved in virus recognition. TRIM5α 
acts as a pattern recognition receptor that confers restriction against HIV-1, HIV-2 and other enveloped 
viruses in a species-specific manner13–16, whereas TRIM21 recognizes opsonized viruses in the cytoplasm 
by binding to the Fc-fragment of the antibody17,18.
TRIM proteins are flexible structural entities that tend to oligomerize upon ligand binding. This 
behavior makes crystallization of full-length TRIM proteins extremely difficult. Hence, only structures 
of TRIM protein fragments are known so far. Crystal structures of B30.2 domains from TRIM5α 19,20, 
TRIM2021, TRIM2522, TRIM7223, and Butyrophilin 3A124 have been determined but only the structures 
of TRIM2118,25 and Ret finger protein-like 4A26 reveal interactions between B30.2 domains and peptide 
ligands. The structures of TRIM69 coiled-coil27, TRIM25 coiled-coil28, and TRIM5α B-box/coiled-coil 
domains29 provide insight into the assembly of the scaffold domain, but the spatial orientation between 
the coiled-coil and B30.2 domains remains elusive.
Here we present the crystal structure of the TRIM20 coiled-coil/B30.2 fragment at 2.4 Å resolu-
tion. This structure shows the overall architecture of TRIM proteins and suggests two distinct spatial 
orientations between B30.2 and coiled-coil domains. The flexibility between the coiled-coil and B30.2 
domains in solution was confirmed by small-angle X-ray scattering (SAXS). We show that the TRIM20 
coiled-coil/B30.2 fragment, but not the isolated B30.2- and coiled-coil domains, binds pro-IL-1β , and 
we discuss different possible binding modes of TRIM5α , a close homologue of TRIM20, to the HIV-1 
CA in light of the presented findings.
Results
Crystal Structure of TRIM20Δ413. To investigate the oligomerisation state and the spatial domain 
orientation of TRIM20 we designed a construct that comprises the TRIM20 coiled-coil and B30.2 
domains. This design was guided by secondary structure prediction of TRIM proteins, which suggested 
that the bipartite coiled-coil motif starts immediately after the B-box domain. The alignment of human 
Figure 1. Central position of the CHS domain in TRIM proteins and its impact on dimerization. (A) 
Schematic representation of the domains of TRIM proteins comprising RING, B-Box, and CHS domains. 
In the literature the CHS domain is referred to as coiled-coil domain with a L2 linker that connects to the 
C-terminal B30.2 domain. TRIM20 is a RING-less TRIM member and has a long N-terminal extension 
composed of a PYD domain and a long linker region. For crystallization a construct starting at position 
414 was designed. (B) Sedimentation velocity analytical ultracentrifugation data of the isolated B30.2 and 
CHS-B30.2 (TRIM20Δ 413) fragments of TRIM20 show a monomer and a dimer, respectively. The molecular 
masses of monomers calculated from the B30.2 and CHS-B30.2 sequences are 23 305 Da and 42 737 Da, 
respectively.
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TRIM5α , − 20, − 21, − 22, and − 27 sequences revealed a conserved glutamic acid at position 414 (Fig. 
S1). Therefore, we engineered a construct starting with E414 yielding a fragment called TRIM20Δ 413 
(Fig.  1A). Analytical ultracentrifugation at 4 °C shows that this C-terminal fragment forms a dimer in 
solution, whereas the isolated TRIM20 B30.2 domain starting at T57721 forms a monomer (Fig. 1B).
TRIM20Δ 413 crystallized in space group P21 with 6 chains in the asymmetric unit (Table S1 and Fig. 
S2A). In the crystal TRIM20Δ 413 forms a clear dimer with a coat-hanger-like shape. Dimerization is 
achieved by the coiled-coil motifs (E414–N586) that form an elongated and slightly bend scaffold for the 
globular B30.2 domain (E589–G776). The B30.2 domain is connected to the scaffold domain by a flexible 
loop (V587-P588) that acts as a hinge (Fig. 2A). Because residues E414–N586 serve as a scaffold to pres-
ent the B30.2 domains we refer to this part of the structure as the central helical scaffold (CHS) domain. 
Each monomer of the CHS domain folds into 4 α -helices (α 1-α 4). Helix α 1 (E414-E520) harbors the 
predicted coiled-coil motif and spans a length of approximately 155 Å (Fig. 2A). The designated L2 linker 
consists of two short helices α 2 and α 3 (E524–K539) followed by a proline-rich extended stretch (T540–
P550) and helix α 4 (Q551–N586). Helices α 2 and α 3, the proline-rich stretch and helix α 4 are oriented 
antiparallel to helix α 1, which is facilitated by a short hairpin loop between α 1 and α 2 (Q522–S523).
The subunits of the TRIM20Δ 413 dimer arrange in an antiparallel fashion along helix α 1 with a 
shared interface of more than 4700 Å2. This interface is created by all four helices including the extended 
stretch. As a result, the presumed B-box domains at the N-termini of TRIM20Δ 413 are positioned 
approximately 170 Å apart from each other, whereas the B30.2 domains are close to the 2-fold axis of 
the dimer. Residues L473 from helix α 1 and F574 from helix α 4 are in direct proximity to the 2-fold 
dimer axis. The bipartite coiled-coil signature sequences (CC) are crucial features for the prediction of 
TRIM proteins. The 2-CC region participates in a 2-helix coiled-coil motif involving residues L427/
L430 and residues L513’/L516’ at the N- and C-termini of helix α 1, respectively (the prime indicates 
residues from the second protomer). The 3-CC region participates in a 3-helix coiled-coil motif involving 
residues L484/V487/V491, I553/I557/L560, and F451’/T455’/L458’ from helices α 1, α 4, and α 1’, respec-
tively (Fig.  2B and C). On the sequence level the 2-CC region is highly conserved in TRIM proteins, 
whereas the 3-CC seems to be TRIM20 specific with little sequence conservation among other TRIM 
proteins (Fig. S1). Furthermore helices α 1, α 1’, α 4, and α 4’ form a four-helix bundle at the core of the 
TRIM20Δ 413 structure close to the 2-fold axis. From this core the B30.2 domains are pointing along the 
2-fold axis and the helical extensions of the core including the L2 linker are slightly bent, reminiscent 
of a coat hanger.
Figure 2. Crystal structure of TRIM20Δ 413. The crystal structure of one out of three dimers from the 
asymmetric unit is shown. Chains A and B are colored in cyan and red, respectively. Helices of each CHS 
domain are numbered α 1 to α 4. The components of the CHS domain that participate in 2-helical (2-CC) or 
3-helical coiled coils (3-CC) are indicated and depicted in more detail in B. (A) The dimer is shown from 
a side and a top view and its dimensions are indicated. (B) Residues involved in the 2-CC (top) and 3-CC 
(bottom) are shown as sticks and labeled in the corresponding color of the helix. (C) Topology of the CHS 
domain including its structural motifs are shown schematically.
www.nature.com/scientificreports/
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Within the TRIM20Δ 413 dimer the B30.2 domains neither interact with each other nor with the CHS 
domain, supporting the assumption that the orientation of the B30.2 domain might be highly flexible in 
solution. The curvature of the CHS domain and the orientations of the B30.2 domains differ among the 
three NCS related dimers (Fig. S2) suggesting that TRIM20 is sufficiently rigid to support lattice forma-
tion but still flexible enough to adopt to spatial constrains that are imposed by the structural environ-
ment. The fact that the TRIM20Δ 413 structure doesn’t reveal an intra-molecular interface between the 
B30.2 and CHS domains is surprising (in this context intra-molecular refers to an interaction within the 
TRIM20Δ 413 dimer), because this interaction was predicted by co-immuno precipitation experiments 
between isolated B30.2 and B-box/CHS constructs8. However, B30.2 and CHS domains share interfaces 
between neighboring dimers (Fig.  3A). These inter-molecular interfaces cover areas between 1710 and 
1950 Å2 and are formed by the extended proline-rich stretch of the CHS domain that runs through a 
shallow surface cleft between the Pry- and Spry segments of the neighboring B30.2 domain (Fig. 3B). The 
B30.2/CHS domain interface harbors several hydrogen bonds and van der Waals interactions.
It is striking to see that helices α 3 and α 4 are separated by helix-breaking proline residues and that 
this extended stretch forms specific interactions with the B30.2 domain. Because of that and since it is 
also a structural feature in the coiled-coil domain of other TRIM or TRIM related proteins, we hypoth-
esize that the interface between the B30.2 domain and the extended proline-rich stretch of the CHS 
domain might be functionally relevant. It could serve as an inter-molecular contact for TRIM oligomer-
ization, but it could also be converted into an intra-molecular contact by a rearrangement of the B30.2/
CHS domain linker. Depending on the linker conformation the B30.2 domain could adopt an open state 
where the B30.2 domain forms an intra-molecular contact to the CHS domain and a closed state with 
no B30.2/CHS domain interface.
Figure 3. Interface between the B30.2 domain and the extended proline-rich stretch. (A) The crystal 
contact between two dimers is shown in a cartoon representation. Chains A and B are colored as in Fig. 2. 
The second dimer made of chain C and D is colored in orange and green, respectively. The black box 
indicates the display detail shown in B. The transition from the closed to the open state would require a 
swapping of the B30.2 domains shown in orange and red. (B) Detailed view of the B30.2/CHS domain 
interface. Residues involved in the interface are depicted in sticks and hydrogen bonds are indicated by black 
dashed lines. A water molecule between the B30.2 domains is shows as a red sphere.
www.nature.com/scientificreports/
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Solution structure of TRIM20Δ413. In order to investigate the conformational flexibility of the 
B30.2 and CHS domains we performed small-angle X-ray scattering (SAXS) experiments. The radius 
of gyration (RG) for an infinitely diluted sample of TRIM20Δ 413 is 4.27 nm, which is consistent with 
the RG calculated from the structure of the dimer in the closed state (4.29 nm; Fig.  4A). However, the 
measured RG value increases with protein concentration, suggesting that dimeric TRIM20Δ 413 forms 
oligomers at elevated protein concentration (Fig. S3A to C). Furthermore, the crystal structure doesn’t fit 
exactly the solution scattering data in the scattering range s = 0.8 to 1.8 nm−1 (χ 2 = 3.62) (Fig. 4A,B) and 
the Kratky-plot reveals inter-domain flexibility (Fig S3D). Therefore, a rigid body model was generated 
by introducing flexibility between the CHS- and the B30.2 domains. This model fits the experimen-
tal scattering data much better than the static model (χ 2 = 2.01). In this model, one of the two B30.2 
domains is arranged as in the crystal structure. The second B30.2 domain is rotated perpendicular to 
the 2-fold axis placing it sideways onto the CHS domain (Fig. 4A,C). Fitting an ensemble of structures 
improved the fit even further (χ 2 = 1.31) and reveals the conformational space available for the B30.2 
domain (Fig. 4A,D).
The conformation seen in the crystal structure defines one populated state in solution. In additional 
we see further states in solution where the B30.2 domains are positioned sideways onto the CHS domain. 
This movement increases the radius where the B30.2 domain could interact with its ligand. In the crystal 
structure the distance between the B30.2 centers of mass is about 47 Å. Movement of the B30.2 domain 
sideways increases this distance to 85 Å (Fig.  4E). Notably, a conformation of the B30.2 domain that 
would resemble an intra-molecular binding to the extended proline-rich stretch of the CHS domain was 
not observed in any model obtained from the SAXS data. The flexibility of the CHS domain, as suggested 
by the NCS of the crystal structure, was not modeled. Nevertheless, conformational flexibility of the CHS 
domain is also suggested by SAXS measurements as the average diameter found in solution is around 
160 Å, which is a little less than in the crystal structure (167 Å).
Pro-IL-1β Binding. Despite the large amount of data on the implication of TRIM20 in FMF, infor-
mation on molecular interaction partners that trigger TRIM20 activation is sparse. Papin and colleagues 
revealed that full-length TRIM20 interacts with pro-IL-1β in a cell-culture system8. To investigate whether 
TRIM20 directly binds to pro-IL-1β in vitro we performed co-immuno precipitation experiments using 
purified pro-IL-1β and various constructs of TRIM20. These results show that TRIM20Δ 413 directly 
binds to pro-IL-1β , whereas the isolated CHS- and B30.2 domains do not (Fig. 5A). To investigate the 
dissociation constant of this interaction we performed surface plasmon resonance (SPR) experiments 
using TRIM20Δ 413 and pro-IL-1β . The data was fitted using the heterogeneous ligand model with 
apparent dissociation constants of 0.70 μ M and 13.7 μ M (Table S3 and Fig. S4A).
Complex formation between TRIM20Δ 413 and pro-IL-1β was also detected by size exclusion chro-
matography (SEC). Stable complex formation however was only observed after incubating the proteins 
at 25 °C, whereas no complex formation was observed after incubation at 4 °C (Fig.  5B and Fig. S4B). 
The sample that was incubated at 25 °C showed a large peak at a retention volume of 1.27 ml corre-
sponding to an apparent molecular weight of approximately 400 kDa (retention volumes: void, 0.8 mL; 
Trim20Δ 413, 1.64 mL; pro-IL-1β , 1.81 mL). Prolonged incubation times at 25 °C yielded even higher 
oligomers (Fig. 5B). Nevertheless, complex formation was reversible. When the complex that was formed 
after 1 h incubation was re-injected, SEC revealed an equilibrium between the complex and the individual 
Figure 4. Solution structure of TRIM20Δ 413. (A) Data extrapolated to infinite dilution is shown together 
with the theoretical curves calculated from the crystal structure, rigid body and ensemble optimized 
structures together with the χ 2 values. (B) The crystal structure is shown in a cartoon representation next 
to the rigid body model (C), three representatives of the ensemble (D), and a schematic illustration of the 
distances between the B30.2 domains found in the crystal structure and the widest arrangement of the 
ensemble (E). The orientation found to be most similar to the crystal structure is shown in a blue surface 
representation. Other orientations of the B30.2 domain found in the rigid body and ensemble fit are colored 
violet and red.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:10819 | DOi: 10.1038/srep10819
components (Fig. S4C). Neither TRIM20Δ 413 nor pro-IL-1β alone showed signs of oligomerization 
upon incubation at 25 °C (Fig. 5C).
Discussion
Structural and functional properties of TRIM20. Several crystal structures of isolated TRIM pro-
tein domains have been reported and the comparison of these TRIM fragments with the TRIM20Δ 413 
structure reveals valuable insight into the function of TRIM proteins Fig. 6A. A comparison of the 
isolated B30.2 domain structures between TRIM20, TRIM21/Fc25 and Ret finger protein-like 4A26 as 
well as mapping of FMF-associated mutations suggested that M694 of TRIM20 is involved in ligand 
binding21. However, in the TRIM20Δ 413 dimer M694 is located close to the 2-fold axis and access to 
this putative peptide binding site is restricted by the B30.2 domain of the second protomer (Figs.  2A 
and 6B). Consequently, the B30.2 domains of TRIM20 have to move away from the 2-fold axis to rec-
ognize a ligand with a diameter of more than 20 Å. Therefore, we refer to the conformation seen in the 
crystal structure of TRIM20Δ 413 as the closed state. The hypothesis that this state is flexible enough to 
be converted into an active conformation is supported by the solution scattering data and the topology 
of TRIM20Δ 413. The best interpretation of the SAXS data is given by an ensemble of TRIM20Δ 413 
structures with B30.2 domains arranged in various conformations along the CHS domain. The topology 
enables this movement, because the B30.2 domain is not restricted by a stiff linker.
Interestingly the TRIM20Δ 413 structure also suggests an open state, where the putative peptide bind-
ing sites are accessible even for very large ligands. The modelling of the open state relies on the assump-
tion that the interaction between the proline-rich stretch and the B30.2 domain that is observed in the 
TRIM20Δ 413 structure as an inter-molecular contact is converted into an intra-molecular contact by a 
rearrangement of the hinge region (Fig. 3A). In the open state the putative peptide binding sites would 
be directly accessible and a distance of approximately 120 Å between M694 residues would allow TRIM20 
to bind to very large ligands with both sites simultaneously (Fig. 6B).
Structural and mutagenesis data support the hypothesis that the interface between the B30.2 domain 
and the extended proline-rich stretch has biological significance. The buried surface of this interface is 
extremely large (approximately 1800 Å2). It is almost three-times as large as the average surface area of 
a crystal contact and the biological significance of a protein/protein interface typically increases with 
its size30. In addition the extended – in the case of TRIM20 proline-rich – stretch is a conserved struc-
tural feature of TRIM proteins. The superposition of the TRIM20Δ 413, TRIM25 coiled-coil28, TRIM69 
coiled-coil27 and TRIM5α B-box/coiled-coil29 structures reveals that the curvatures of the CHS domains 
are extremely variable, but the topology of the helix bundle comprising the C-terminus of helix α 1, the 
L2 linker, the extended stretch and the N-terminus of helix α 1’ is conserved in all structures (Fig. 6A). 
The L2 linker is conserved, because it positions the B-box domain. Likewise, the insertion of an extended 
Figure 5. Interaction between TRIM20 and pro-IL-1β . (A) 10 μ M of the TRIM20 constructs 
were incubated with 10 μ g FLAG-tagged pro-IL-1β in a total volume on 100 μ l. Complex was co-
immunoprecipitated using ANTI-FLAG® M2 Affinity Gel (Sigma-Aldrich) and subjected to SDS-PAGE 
analysis. (B) TRIM20Δ 413 and pro-IL-1β were incubated as indicated and their SEC profiles are shown 
together with the corresponding retention volumes of 1.27 ml, 1.64 ml, and 1.81 ml for the complex after 
1 h incubation, TRIM20Δ 413 and pro-IL-1β , respectively. Co-elution of both proteins was verified by SDS-
PAGE of the indicated fractions. (C) Elution profiles of the individual proteins incubated for 4 h at 25° C 
show no signs of peak shifts.
www.nature.com/scientificreports/
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stretch between helices α 3 and α 4 can be explained by its role in either positioning the B30.2 domain 
in the open state of TRIM20 or the formation of a TRIM20 tetramer.
The mapping of mutations involved in FMF on the surface of the isolated TRIM20 B30.2 domain 
leads to the hypothesis that the B30.2 domain recognizes different ligands involving spatially separated 
binding sites21. This hypothesis is corroborated by the TRIM20Δ 413 structure and in fact the biological 
significance of the B30.2/CHS domain interface is supported by the observation that mutations that are 
associated with mild forms of FMF, Crohn’s disease or arthritis, such as P550A31, L649P32, S650Y and 
R653H33, are directly involved in this interface (Fig. 3B). Mutations I591T34 and A595V are located in 
the linker between the CHS and B30.2 domains. These mutations could shift the equilibrium between 
the open- and closed states and thereby the affinity for the TRIM20 ligand.
On the other hand the arrangement of B30.2 domains as it is proposed for the open state was not 
observed among the ensemble of structures in the SAXS experiments. SAXS experiments suggested that 
TRIM20Δ 413 has sufficient flexibility to reach this state, but the B30.2 domains never locked into a 
conformation seen in the B30.2/proline-rich stretch interface. The absence of this conformation from the 
ensemble of SAXS structures can be explained by the lack of a TRIM20 ligand. Perhaps the open state 
is only populated in a TRIM20/ligand complex. On the other hand TRIM20Δ 413 formed higher order 
oligomers at elevated protein concentration in the SAXS measurements and the interaction between the 
B30.2 domain and the proline-rich stretch could explain this behavior.
The observation that isolated TRIM20 B30.2- and CHS domains were unable to bind pro-IL-1β con-
firms that dimerization of TRIM20 by means of the CHS domain is required for binding. The apparent 
molecular mass of 400 kDa suggests that the TRIM20Δ 413/pro-IL-1β complex will most likely consist 
of several TRIM20Δ 413 (85.7 kDa dimer) and pro-IL-1β (31.9 kDa) subunits and indicates that com-
plex formation requires oligomerization of TRIM20Δ 413 and/or pro-IL-1β . Additional experiments are 
required to reveal the exact stoichiometry of the TRIM20/pro-IL-1β complex. Complex formation also 
requires elevated temperature, because at 4 °C no interaction between TRIM20Δ 413 and pro-IL-1β was 
detected. It is unlikely that the 400 kDa peak in the size exclusion chromatogram indicates temperature 
Figure 6. (A) Superposition of CHS domains of TRIM20Δ 413 (chains C and D in cyan and green, 
respectively), TRIM5α B-box/coiled-coil (CHS-domain and B-box domains in salmon and red, 
respectively)29, TRIM25 coiled-coil (orange)28, and TRIM69 (grey)27. Helices α 1 (N- and C-termini), α 3, 
α 4 and the extended stretch are labeled. (B) Illustration of open- and closed states. Crystal structure of 
TRIM20Δ 413 (chains C and D are shown in red and cyan, and the B30.2 domains of chains B and E in 
orange and blue, respectively). B30.2 domains in orange/blue and red/cyan indicate the open- and closed 
states, respectively. The side chain of M694 from the putative peptide binding site of TRIM20 is shown as 
blue spheres. The hinge region for swapping between open and closed states is indicated by grey spheres. 
Distances between M694 residues are shown as dashed lines. (C) Three docking models for the binding of 
TRIM5α to HIV-1 CA. 19 CA hexamers (equivalent to 114 CA subunits) are shown as spheres in salmon 
and grey. TRIM5α is shown as ribbons. The asymmetric unit of the lattice is indicated by a blue dashed line 
(a = b = 187 Å, γ = 120°). Some 6-, 3- and 2-fold axes are shown as blue hexagons, triangles and ellipses, 
respectively. A second unit cell is shown in lighter colors. (i.) Model of the symmetric dimer in the closed 
state. (ii.) Model of the symmetric tetramer. (iii.) Model of the asymmetric dimer. Ribbons in magenta are 
experimental structures representing the closed state. Ribbons in green represent the open state that was 
modeled assuming a domain swapping of the B30.2 domain as described in the text.
www.nature.com/scientificreports/
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induced unfolding and unspecific aggregation, because the isolated components did not show any sign 
of aggregation at this temperature. The premise of elevated temperature could indicate that larger, 
temperature-induced structural rearrangements are required for binding.
Modelling of TRIM interaction. Unfortunately neither the structure of pro-IL-1β nor the exact 
stoichiometry of this complex is known and attempts to crystallize it were so far unsuccessful. To 
exemplify how the CHS-domain, which has the same structural topology in many TRIM proteins 
(Fig. 6A), is involved in the recognition of higher order oligomers, we modelled the complex between 
TRIM5α and the HIV-1 CA lattice (pdb entry: 3dik)35 in a qualitative manner. TRIM20 differs from 
many other TRIM proteins including TRIM5α by a different domain composition. TRIM5α harbors 
a RING domain 30 amino acids N-terminal to the B-box 2 domain that was shown to participate in 
higher order self-association, whereas in TRIM20 a PYD domain is connected to the B-box 2 domain 
by a 60 or 280 amino acid linker. Since human TRIM5α and TRIM20 both comprise CHS- and B30.2 
domains at the C-terminus of the B-box 2 domain, the TRIM20Δ 413 structure is a suitable template to 
model the TRIM5α /CA interaction. Furthermore, the L2 region of TRIM5α was shown to contribute to 
self-assembly and CA recognition36 and mutations within the proline-rich stretch were found to abrogate 
HIV-1 restriction activity37,38. Mutations on the TRIM5α B30.2 domain that impair retroviral restriction 
activity but do not map to the predicted CA binding surface39,40 support the hypothesis that the interac-
tions between the B30.2 domain and the proline-rich stretch also apply to TRIM5α .
We investigated two symmetric dimers with strict 2-fold symmetry (TRIM20Δ 413 with both B30.2 
domains in the same open- or closed conformation, Fig. 6B and model i. in Fig. 6C), a symmetric tetramer 
composed of chains C, D, E, and F from the TRIM20Δ 413 crystal structure (model ii. in Fig. 6C) and 
an asymmetric dimer comprising a mixture of B30.2 domains in open- and closed states (model iii. in 
Fig.  6c). All three models (Fig.  6C) agree with mutagenesis data on TRIM5α /CA interaction41–48 and 
revealed lattice constants of 187 Å, which are in good agreement with the experimentally determined 
lattice constant of TRIM5α 35. In the model of the symmetric dimer with the B30.2 domains in the 
closed state (model i.) the assumed peptide binding sites of B30.2 domains are not directly accessible. 
This model is almost identical to the models suggested by Sanchez et al. (2014) and Goldstone et al. 
(2014) that were build based on the structures of TRIM25 coiled-coil and TRIM5α B-box/coiled-coil 
domains, respectively28,29. However, the SAXS data on TRIM20Δ 413 confirms that the B30.2 domains 
are sufficiently flexible to move into a conformation that allows direct recognition of HIV-1 CA. The 
main limitation of this model comes from the observation that the B-box 2 domains are predicted to 
form trimers although it was shown by NMR and analytical ultracentrifugation that the TRIM5α B-box 
2 domains form dimers in solution49. The model of the symmetric dimer with the B30.2 domain in the 
open state (data not shown) has the same limitation. The docking of symmetric dimers suggests a stoi-
chiometry of TRIM5α to CA of 1:12.
These limitations are eliminated if it is assumed that the TRIM lattice is composed of tetramers 
(model ii. in Fig. 6c). Here, the B30.2 domain serves a dual function. Two B30.2 domains build up the 
tetramer by binding to the extended stretch and the remaining two B30.2 domains interact with the CA. 
In this model the distance between the putative peptide binding sites of B30.2 domains fit exactly the 
diameter of the CA hexamer. Thus, two CA subunits can be recognized by two B30.2 domains simulta-
neously and the B-box 2 domains would form dimers. In the tetramer model B-box/B-box and B30.2/
CHS domain interactions are required to build the TRIM lattice, but it was shown that lattice formation 
does not require the B30.2 domain35. Thus, the tetramer model can only be valid under the assumption 
that additional interactions between B-box 2 domains (besides dimerization) are responsible for lattice 
formation.
The third option would be an asymmetric dimer with one chain in the open- and the second chain in 
the closed state (model iii. in Fig. 6c). This model relies on the assumption that the inter-molecular inter-
face between the B30.2 domain and the extended stretch is transformed into an intra-molecular interface 
by a rearrangement of the linker region (Fig.  6B). In this model the putative peptide binding sites of 
both B30.2 domains could directly interact with the CA epitope and the B-box 2 domains would form 
dimers. In this model the B30.2 only serves for capsid recognition. Therefore, elimination of the B30.2 
domain does not prevent lattice formation. In this model two B-box 2 dimers line up along the six-fold 
axis of the hexamer (Fig. S5). Hence, additional interactions between B-box 2 dimers are also envisaged 
for this model. Furthermore, this model suggests weak electron density around the 3-fold axis, which 
disagrees with the projection density map of the TRIM5α /CA electron microscopy structure35. Models 
ii. and iii. suggest 1:6 stoichiometries for TRIM5α to CA. In summary, none of the models combines 
all experimental findings and all three models have their strengths and weaknesses. Therefore, further 
experimental evidence, e.g. the experimental analysis of the Trim5α /CA interaction stoichiometry, is 
needed to resolve these issues. It is hoped that the various models presented here would trigger efforts 
in this direction.
Experimental Procedure. Cloning, expression and purification, SAXS experiments, co-immuno pre-
cipitation experiments, surface Plasmon resonance analysis, size exclusion experiments and model build-
ing are described in the supplementary material file.
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Crystallization and structure determination. First crystals were found in 0.1 M Tris-AcOH, pH 
8–8.5, 0.2–0.4% (w/v) Cystamine, 0.2 M LiSO4, 8% (w/v) PEG 20’000, 8% (w/v) PEG 550 MME using 
sitting drop vapor diffusion at 20 °C. TRIM20Δ 413 (7.5 mg/ml) was mixed in a 1:1 ratio with mother 
liquor. The obtained crystals were used for micro-seeding in 0.1 M Tris-AcOH, pH 7.4–8.0, 0.26% (w/v) 
Cystamine, 0.2 M LiSO4, 8% (w/v) PEG 20’000, 8% (w/v) PEG 550 MME using sitting drop vapor dif-
fusion at 20 °C. The protein sample was concentrated to 5 mg/ml and mixed in a 1:1 ratio. Crystals 
grew within 24 h and were harvested within 18 days. Prior to flash freezing in liquid nitrogen, crystals 
were soaked in the mother liquor supplemented with 20% (v/v) ethylene glycol. A native data set of a 
TRIM20Δ 413 crystal was recorded at the X06SA beam line of the Swiss Light Source (Paul-Scherrer 
Institut, Villigen, Switzerland). The protein crystallized in P21 with 6 molecules in the asymmetric unit 
forming 3 dimers. Data was indexed, integrated and scaled with XDS50 to a resolution of 2.4 Å. Molecular 
replacement was done with Phaser51 using the B30.2 domain of TRIM20 as search model (pdb entry: 
2wl1). Model building and manual fitting was done in Coot52. Refinement was performed with Phenix53. 
In the final model, 98% of all residues are in the favored Ramachandran area and no outliers were 
detected.
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